1-3 of 3
Pierce Sherry
Close
Sort by
Journal Articles

Prognostic Factors for Outcome in Patients (pts) with Refractory and Relapsed Acute Lymphocytic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (IO), a CD22 Monoclonal Antibody

Elias Jabbour, MD, Susan O'Brien, MD, Koji Sasaki, Xuelin Huang, PhD, Deborah A. Thomas, MD, Michael E. Rytting, MD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Pierce Sherry, RN, Tapan M. Kadia, MD, Kantarjian Hagop, MD
Journal: Blood
Blood (2014) 124 (21): 2288.
https://doi.org/10.1182/blood.V124.21.2288.2288
Published: 2014
Journal Articles

Outcomes of Patients with Newly-Diagnosed Acute Myeloid Leukemia Over the Last 5 Decades At M.D. Anderson Cancer Center

Alfonso Quintás-Cardama, MD, Hagop Kantarjian, Farhad Ravandi, MBBS, Guillermo Garcia-Manero, Stefan Faderl, MD, Pierce Sherry, Mark Brandt, Gautam Borthakur, Michael Keating, MD, Emil Freireich, Jorge E Cortes
Journal: Blood
Blood (2011) 118 (21): 2606.
https://doi.org/10.1182/blood.V118.21.2606.2606
Published: 2011
Journal Articles

Effect of FLT3 and RAS Mutations on Protein Expression Patterns In Cases of Acute Myelogenous Leukemia (AML) with NPM1 Mutations

Steven M. Kornblau, MD, Yujia Huo, BS, Mark Brandt, Nianxiang Zhang, Ph.D, Yi Hua Qiu, MD, Farhad Ravandi, MD, Tapan Kadia, MD, Pierce Sherry, Kevin R Coombes, Ph.D, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 2704.
https://doi.org/10.1182/blood.V116.21.2704.2704
Published: 2010